Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02043847 · OUTCOME

Maximum Tolerated Dose (MTD) of Gy

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03) · Source last updated 2024-11-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 60 days post-transplant.

What was measured

Assessing MTD of TMI of 3Gy, 6Gy and 9Gy

Analysis population: 3 participants received 3Gy, 3 participants received 6Gy and 6 participants received 9Gy

Groups in this outcome

Single Arm

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Single Arm12

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Single ArmNANot reportedNot reportedNot reportedTo clarify there was an insufficient number of events to determine the MTD
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        To clarify there was an insufficient number of events to determine the MTD
        group Id
        OG000
        value
        NA
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    units
    Participants
description
Assessing MTD of TMI of 3Gy, 6Gy and 9Gy
groups
  1. id
    OG000
    title
    Single Arm
param Type
COUNT_OF_PARTICIPANTS
population Description
3 participants received 3Gy, 3 participants received 6Gy and 6 participants received 9Gy
reporting Status
POSTED
time Frame
Up to 60 days post-transplant.
title
Maximum Tolerated Dose (MTD) of Gy
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice